OCD Trial, Recruiting (NCT06628752)

OCD Trial, Recruiting NCT06628752 Sponsor: Umeå University Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT06628752 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Obsessive-Compulsive Disorder (OCD) according to standard medical guidelines (DSM-IV).
You have completed at least 16 sessions of talking therapy (cognitive behavioral therapy) for OCD.
You have tried at least three different antidepressant medications at the right doses for at least three months each, and also tried one of those antidepressants combined with an antipsychotic medication.
Your OCD symptoms are considered severe, based on a standard scoring test called the YBOCS (scoring 25 points or higher).
Your OCD symptoms significantly affect your ability to function in daily life.
You have had OCD symptoms for at least 5 years.
You are able to understand what taking part in the study involves and are willing to sign a written consent form.

Who may not be able to join:

You are not able to understand what the treatment involves or what the consequences of participating might be.
You have been diagnosed with an intellectual disability according to standard medical guidelines (DSM-IV).
You do not meet the medical requirements needed to safely undergo a brain surgery procedure (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patric Blomstedt, Professor, Umeå University

Phone: +46-90-786 50 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06628752

Sponsor: Umeå University

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: +46-90-786 50 00

More information: https://clinicaltrials.gov/study/NCT06628752

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Obsessive-Compulsive Disorder (OCD) according to standard medical guidelines (DSM-IV).
You have completed at least 16 sessions of talking therapy (cognitive behavioral therapy) for OCD.
You have tried at least three different antidepressant medications at the right doses for at least three months each, and also tried one of those antidepressants combined with an antipsychotic medication.
Your OCD symptoms are considered severe, based on a standard scoring test called the YBOCS (scoring 25 points or higher).
Your OCD symptoms significantly affect your ability to function in daily life.
You have had OCD symptoms for at least 5 years.
You are able to understand what taking part in the study involves and are willing to sign a written consent form.

Who may not be able to join:

You are not able to understand what the treatment involves or what the consequences of participating might be.
You have been diagnosed with an intellectual disability according to standard medical guidelines (DSM-IV).
You do not meet the medical requirements needed to safely undergo a brain surgery procedure (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Umeå University

Registry

ClinicalTrials.gov

Start date

11 September 2018

Est. completion

31 December 2030

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Yale-Brown Obsessive Compulsive Scale, Y-BOCS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov